Clinical Trials Browser

Phase 1 × Cardiotoxicity × Razoxane × Clear all

NCT00039481 2013-01-17

Oblimersen Plus Combination Chemotherapy and Dexrazoxane in Treating Children and Adolescents With Relapsed or Refractory Solid Tumors

Phase 1 Completed

Cardiotoxicity